Publications by authors named "Simran Venkatraman"

Claim this Profile
A
Analysis of menstrual effluent uncovers endometriosis-specific cell populations and impaired cellular pathway processes.
Taylor R Wilson, Stephanie A Morris, Paul L Deford, Andrea Starostanko, Susan Kasper, Simran Venkatraman

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Evaluation of an Electronic Health Record-Generated Clinical Coverage Scoring System Compared to Human Decision-Making in Pediatric Surgical Patients: A Single Center Experience.
Pornswan Ngamprasertwong, Annie R Amin, Jiwon Lee, Lili Ding, Bobby R Das, Simran Venkatraman

Paediatr Anaesth· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro.
Paul L Deford, Andrew P VonHandorf, Brian G Hunt, Simran Venkatraman, Susan E Waltz

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potassium channels mediate the inhibitory effect of exosomes on anti-tumor immunity in head and neck cancer.
Ameet A Chimote, Abdulaziz O Alshwimi, Simran Venkatraman, Jay Bhati, Maria A Lehn

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.
Simran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, Supaporn Yangngam, Nisa Chuangchot

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells.
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.
Simran Venkatraman, Brinda Balasubramanian, Chanitra Thuwajit, Jaroslaw Meller, Rutaiwan Tohtong

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.
Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote

Pharmaceuticals (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma.
Kyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, Brinda Balasubramanian, Simran Venkatraman

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.
Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, Kyaw Zwar Myint, Jitlada Juengsamarn

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.
Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Sucheewin Krobthong, Patompon Wongtrakoongate

Molecules· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach.
Simran Venkatraman, Brinda Balasubramanian, Pisut Pongchaikul, Rutaiwan Tohtong, Somchai Chutipongtanate

Genes (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach.
Brinda Balasubramanian, Simran Venkatraman, Tavan Janvilisri, Tuangporn Suthiphongchai, Siriporn Jitkaew

Pharmaceuticals (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells.
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Simran Venkatraman

Cancer Res Treat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma.
Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Tavan Janvilisri, Kanokpan Wongprasert

Pharmaceuticals (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy.
Simran Venkatraman, Jarek Meller, Suradej Hongeng, Rutaiwan Tohtong, Somchai Chutipongtanate

Vaccines (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis